Supplementary document for Effective Bandgap Narrowing and Enhanced Optoelectronic Performance of Cs2PtBr6 Double Perovskites by Pressure Engineering - 6791456.pdf

Supplemental Document 50975

Supplementary material.doc

The phonon spectrum, electronical and optical properties of of Cs2PtBr6 under different pressure

Additional file 1 of Cardiovascular protective effect of sodium-glucose cotransporter 2 inhibitors on patients with acute coronary syndrome and type 2 diabetes mellitus: a retrospective study

Additional file 1: Table S1. Univariate and multivariate analyses of adverse cardiovascular outcomes. Table S2. Univariate and multivariate analyses of rehospitalization for ACS or HF. Table S3. Multivariate analyses of each component of rehospitalization. Table S4. Univariate and multivariate analyses of cardiovascular mortality. Table S5. Univariate and multivariate analyses of angina symptom control rate

Prolonging Time to Flare in Pediatric Atopic Dermatitis: A Randomized, Investigator-Blinded, Controlled, Multicenter Clinical Study of a Ceramide-Containing Moisturizer

<p><strong>Article full text</strong></p> <p><br> The full text of this article can be found <a href="https://link.springer.com/article/10.1007/s12325-017-0640-6"><b>here</b>.</a><br> <br> <strong>Provide enhanced digital features for this article</strong><br> If you are an author of this publication and would like to provide additional enhanced digital features for your article then please contact <u>[email protected]</u>.<br> <br> The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.<br> <br> Other enhanced features include, but are not limited to:<br> • Slide decks<br> • Videos and animations<br> • Audio abstracts<br> • Audio slides<u></u></p

3-dimensional map of genetic variation estimates.

<p>Views (clockwise from top left): right lateral (A), anterior (B), superior (C), inferior (F), posterior (E), and left lateral (D). Hotter colors (black</p

Participants' gender and baseline age by study group.

<p>Gender and baseline age distribution by study group. Chi-squared test of independence between gender and study group yields a p-value of 0.02. ANOVA F-test for differences in mean age between study groups yields a p-value of 0.18.</p

Genetic Variation estimates for major regional brain volumes.

<p>Genetic variation estimates, standard errors, and associated likelihood ratio tests for four aggregated volumes.</p

Genetic variation estimates and additional results for non-overlapping brain regions.

<p>Genetic variation estimates (top left; A) and the associated −log₁₀p-values from LRT (top right; B). Hotter colors (black</p

Genetic variation estimates and associated clustering results for ROI volumes.

<p>Genetic variation estimates, standard errors, associated LRT p-values, and clustering results for 93 non-overlapping ROIs.</p

Begg’s test.

ObjectiveCoronary artery disease (CAD) is a leading cause of death worldwide. Many studies in China and abroad have reported an association between the expression level of microRNA-155 and CAD; however, the results remain controversial. We aimed to comprehensively investigate this association based on a meta-analysis.MethodsWe first systematically searched eight Chinese and English databases, including China National Knowledge Infrastructure, Wanfang, China Science and Technology Journal Database, PubMed, Web of Science, Embase, Google Scholar, and Cochrane Library, to identify studies concerning the relationship between microRNA-155 levels and CAD published before February 7, 2021. The quality of the literature was assessed by the Newcastle–Ottawa Scale (NOS). Meta-analysis was performed using a random-effects model to calculate the standard mean difference with a 95% confidence interval (CI).ResultsSixteen articles with a total of 2069 patients with CAD and 1338 controls were included. All the articles were of high quality according to the NOS. The meta-analysis showed that the mean level of microRNA-155 was significantly lower in patients with CAD than in controls. Based on subgroup analyses, the level of microRNA-155 in the plasma of CAD patients and in acute myocardial infarction (AMI) patients was significantly lower than that in controls, whereas this level in CAD patients with mild stenosis was significantly higher than that in controls.ConclusionOur study indicates that the expression level of circulating microRNA-155 in patients with CAD is lower than that in a non-CAD group, suggesting a new possible reference index for the diagnosis and monitoring of patients with CAD.</div